Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Steinschifter

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Laryngo- Rhino- Otologie|December 8, 1998
[Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck]W Anderhuber, W Steinschifter, A Gotschuli, et al.
Cancer|April 15, 1997
Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissueE Schauenstein, H Rabl, W Steinschifter, et al.
Cancer|August 1, 1996
Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiencyE Schauenstein, M Lahousen, M Weblacher, et al.
British Journal of Cancer|April 17, 1999
The IgG1/G2 subclass shift--a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neckW Anderhuber, W Steinschifter, E Schauenstein, et al.
Journal of Biochemical and Biophysical Methods|June 9, 1997
Interheavy disulfide bridge in immunoglobulin G (IgG) reacting with dithionitrobenzoate. A unique feature in serum proteinsR Horejsi, G Kollenz, F Dachs, et al.
Cancer|January 21, 2000
The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignanciesP Felsner, W Steinschifter, M Fischer, et al.
Biochemistry and Molecular Biology International|October 1, 1996
Reactive disulfide bonds in immunoglobulin G. A unique feature in serum proteins of different speciesE Schauenstein, K Schauenstein, F Dachs, et al.
Breast Cancer Research and Treatment|February 24, 2001
Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancerL Kronberger, W Steinschifter, M Weblacher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Laryngo- Rhino- Otologie|December 8, 1998
[Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck]W Anderhuber, W Steinschifter, A Gotschuli, et al.
Cancer|April 15, 1997
Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissueE Schauenstein, H Rabl, W Steinschifter, et al.
Cancer|August 1, 1996
Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiencyE Schauenstein, M Lahousen, M Weblacher, et al.
British Journal of Cancer|April 17, 1999
The IgG1/G2 subclass shift--a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neckW Anderhuber, W Steinschifter, E Schauenstein, et al.
Journal of Biochemical and Biophysical Methods|June 9, 1997
Interheavy disulfide bridge in immunoglobulin G (IgG) reacting with dithionitrobenzoate. A unique feature in serum proteinsR Horejsi, G Kollenz, F Dachs, et al.
Cancer|January 21, 2000
The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignanciesP Felsner, W Steinschifter, M Fischer, et al.
Biochemistry and Molecular Biology International|October 1, 1996
Reactive disulfide bonds in immunoglobulin G. A unique feature in serum proteins of different speciesE Schauenstein, K Schauenstein, F Dachs, et al.
Breast Cancer Research and Treatment|February 24, 2001
Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancerL Kronberger, W Steinschifter, M Weblacher, et al.
Pageof 1